Roivant Sciences Ltd (ROIV)

03:25 AM

Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing - Insider Monkey

03:25 AM

Jan 01, 2025

10 Firms End 2024 Stronger With Impressive Gains - Insider Monkey

Jan 01, 2025

Jan 01, 2025

Strategic Sale: Eric Venker Decides To Exercise Options Worth $3.86M At Roivant Sciences - Benzinga

Jan 01, 2025

Dec 31, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $2,050,704.16 in Stock - MarketBeat

Dec 31, 2024

Dec 31, 2024

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 176,900 Shares of Stock - MarketBeat

Dec 31, 2024

Dec 31, 2024

Roivant Sciences' president sells common shares worth $4.1 million - Investing.com

Dec 31, 2024

Dec 30, 2024

Principal Financial Group Inc. Has $11.65 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 30, 2024

Dec 27, 2024

Roivant sciences president Eric Venker sells $1.15 million in shares By Investing.com - Investing.com Australia

Dec 27, 2024

Dec 26, 2024

Eric Venker Sells 100,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 26, 2024

Dec 26, 2024

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CIO Sells 689,495 Shares of Stock - MarketBeat

Dec 26, 2024

Dec 26, 2024

Mayukh Sukhatme Sells 185,946 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 26, 2024

Dec 26, 2024

Roivant Sciences’ CIO Mayukh Sukhatme sells $10.6m in shares By Investing.com - Investing.com Nigeria

Dec 26, 2024

Dec 26, 2024

Roivant Sciences' CIO Mayukh Sukhatme sells $10.6m in shares By Investing.com - Investing.com South Africa

Dec 26, 2024

Dec 26, 2024

Roivant Sciences' CIO Mayukh Sukhatme sells $10.6m in shares - Investing.com India

Dec 26, 2024

Dec 26, 2024

Roivant sciences president Eric Venker sells $1.15 million in shares - Investing.com

Dec 26, 2024

Dec 21, 2024

Barclays PLC Buys 75,609 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 21, 2024

Dec 20, 2024

Mayukh Sukhatme Sells 412,584 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat

Dec 20, 2024

Dec 20, 2024

Roivant sciences executive sells common shares worth $4.97 million - Investing.com India

Dec 20, 2024

Dec 20, 2024

Geode Capital Management LLC Acquires 1,460,205 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 20, 2024

Dec 19, 2024

Retirement Systems of Alabama Buys 112,286 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 19, 2024

Dec 17, 2024

Ramaswamy Urges BuzzFeed to Cut Jobs, Air More Conservative Voices - MSN

Dec 17, 2024

Dec 16, 2024

Trump administration will have financial ties to biotechs - BioCentury

Dec 16, 2024

Dec 12, 2024

State Street Corp Buys 1,118,561 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 12, 2024

Dec 09, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 09, 2024

Dec 07, 2024

What is Leerink Partnrs' Estimate for ROIV Q3 Earnings? - MarketBeat

Dec 07, 2024

Dec 06, 2024

Several Positive Developments Lifted Roivant (ROIV) in Q3 - Insider Monkey

Dec 06, 2024

Dec 06, 2024

Edgestream Partners L.P. Buys Shares of 48,226 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 06, 2024

Dec 05, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 762,953 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 05, 2024

Dec 05, 2024

MetLife Investment Management LLC Has $2.60 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Roivant to stop lung disease drug development after trial failure - MSN

Dec 04, 2024

Dec 04, 2024

Roivant Sciences: A Biotech Growth Play With Major Ambitions (NASDAQ:ROIV) - Seeking Alpha

Dec 04, 2024

Dec 04, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Holdings Cut by Melqart Asset Management UK Ltd - MarketBeat

Dec 04, 2024

Dec 04, 2024

Maven Securities LTD Purchases Shares of 400,000 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 04, 2024

Dec 04, 2024

Charles Schwab Investment Management Inc. Buys 646,627 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 04, 2024

Dec 03, 2024

Roivant Phase II miss for namilumab - The Pharma Letter

Dec 03, 2024

Dec 03, 2024

Erste Asset Management GmbH Buys New Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 03, 2024

Dec 03, 2024

Roivant Sciences Ends Namilumab Study Due to Inefficacy - TipRanks

Dec 03, 2024

Dec 03, 2024

Roivant falls as lung disease drug fails in mid-stage study - XM

Dec 03, 2024

Dec 02, 2024

TOMS Capital Investment Management LP Invests $46.33 Million in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 02, 2024

Dec 01, 2024

Thrivent Financial for Lutherans Sells 62,228 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Dec 01, 2024

Nov 29, 2024

Fmr LLC Increases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 29, 2024

Nov 27, 2024

Rubric Capital Management LP Sells 600,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 27, 2024

Nov 26, 2024

Loomis Sayles & Co. L P Has $45.15 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 26, 2024

Nov 22, 2024

Roivant Sciences president Eric Venker sells $1.13 million in shares By Investing.com - Investing.com Nigeria

Nov 22, 2024

Nov 22, 2024

Roivant Sciences president Eric Venker sells $1.13 million in shares - Investing.com

Nov 22, 2024

Nov 22, 2024

Thompson Siegel & Walmsley LLC Takes $5.93 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 22, 2024